Silo Pharma, Inc.
SILO
$2.15
-$0.13-5.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.44% | -86.85% | 20.61% | 7.80% | -16.76% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 16.00% | -19.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.37% | 461.39% | -72.33% | 3,343.64% | 668.97% |
| Change in Net Operating Assets | 111.66% | -3.40% | 85.85% | -316.62% | 83.60% |
| Cash from Operations | 4.95% | -5.42% | 18.34% | 25.66% | 21.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 877.12% | 95.46% | -444.50% | -124.61% | -55.46% |
| Cash from Investing | 877.12% | 95.46% | -444.50% | -124.61% | -55.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 235.69% | -69.68% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 235.69% | -69.68% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.09% | -201.82% | 299.78% | -134.76% | 255.65% |